1. Home
  2. GHC vs INDV Comparison

GHC vs INDV Comparison

Compare GHC & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Graham Holdings Company

GHC

Graham Holdings Company

SELL

Current Price

$1,194.73

Market Cap

4.9B

Sector

Real Estate

ML Signal

SELL

Logo Indivior PLC

INDV

Indivior PLC

SELL

Current Price

$33.50

Market Cap

4.2B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
GHC
INDV
Founded
1877
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9B
4.2B
IPO Year
1994
2014

Fundamental Metrics

Financial Performance
Metric
GHC
INDV
Price
$1,194.73
$33.50
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $49.00
AVG Volume (30 Days)
25.6K
★ 1.7M
Earning Date
10-28-2026
10-29-2026
Dividend Yield
★ 0.63%
N/A
EPS Growth
N/A
★ 8100.00
EPS
★ 71.04
1.67
Revenue
★ $2,932,099,000.00
$1,239,000,000.00
Revenue This Year
$5.98
$7.50
Revenue Next Year
$4.03
$5.07
P/E Ratio
★ $16.86
$20.12
Revenue Growth
N/A
★ 4.29
52 Week Low
$974.00
$23.72
52 Week High
$1,262.35
$42.81

Technical Indicators

Market Signals
Indicator
GHC
INDV
Relative Strength Index (RSI) 67.83 33.24
Support Level $1,104.70 $32.06
Resistance Level $1,221.02 $35.70
Average True Range (ATR) 24.79 1.03
MACD 6.04 -0.23
Stochastic Oscillator 90.66 0.27

Price Performance

Historical Comparison
GHC
INDV

About GHC Graham Holdings Company

Graham Holdings Company is a diversified holding company with operations spanning educational services, television broadcasting, healthcare, manufacturing, automotive dealerships, and other businesses. The Company's education activities are conducted through Kaplan, whose services include academic preparation programs for international students, English-language programs, exam preparation, and career and academic advisement. These services are provided to students, schools, and colleges, both domestically and outside the United States. It operates through seven reportable segments: Kaplan International, Kaplan Higher Education, Kaplan Supplemental Education, Television Broadcasting, CSI, Manufacturing and Automotive, with key revenue coming from the Education and Automotive segments.

About INDV Indivior PLC

Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).

Share on Social Networks: